TBI: Traumatic Brain Injury Feasibility Study (EPIC-011)

Sponsor
Epic Research & Diagnostics, Inc. (Industry)
Overall Status
Unknown status
CT.gov ID
NCT02471625
Collaborator
(none)
200
1

Study Details

Study Description

Brief Summary

The purpose of this research study is to evaluate whether data made by the ClearView System can be used to detect whether someone has a traumatic brain injury and how severe the injury is.

Condition or Disease Intervention/Treatment Phase
  • Device: ClearView Scanning

Detailed Description

Traumatic brain injury (TBI) is a significant cause of death and disability in the U.S. The severity of a TBI may range from "mild" (i.e. a brief change in mental status or consciousness) to "severe" (i.e. an extended period of unconsciousness or memory loss after the injury). However, most TBI's that occur each year are mild and are commonly called concussions. Unfortunately, TBI terminology does not adequately describe the injury or impairment, its treatment, or the resulting outcomes. Due to the complexity of the human brain, each person's physiology can result in different patterns of impairment and secondary conditions, requiring different treatment or rehabilitation. The intent of EPIC ClearView™ TBI Feasibility (EPIC-011) is to collect data to further develop the ClearView™ Response Scale to measure electrophysiology associated with TBI

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™
Study Start Date :
Apr 1, 2015
Anticipated Primary Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Traumatic Brain Injury

Men and women ages 18-65 with suspected acute head trauma within 24-72hrs. of presentation, scoring a 3-15 on initial evaluation on GCS scale.

Control

Men and women ages 18-65 with no history of head trauma and a score of 15 on the GCS scale.

Device: ClearView Scanning

Outcome Measures

Primary Outcome Measures

  1. Agreement of ClearView Scan versus Active Diagnosis [I day unless TBI population chooses to participate in one week follow up]

    The EPIC ClearView software produces a Response Scale report that summaries the electrophysiological measurements associated with organ systems. The autonomic numbers indicate how the person's stress response is affecting different body systems and the physical numbers reflect physiological function. These measurements will then be compared to TBI diagnosis, based on one or two possible scans

Secondary Outcome Measures

  1. Comparison of TBI subjects to Controls [1 day unless TBI population chooses to participate in one week follow up]

    Will measure comparisons of data from one visit

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Suspected TBI population:
  1. Acute head trauma within 24-72 hours of presentation

  2. 18-65 age inclusive

  3. GCS of 3-15 on initial evaluation in ED

Control population:
  1. 18-65 age inclusive

  2. GCS score of 15

Exclusion Criteria:
  1. Current neurological disease

  2. Current severe psychological disorder

  3. History of substance or alcohol abuse

  4. Under drug or alcohol influence, if so, must wait at least 24 hrs. prior to consent

  5. Documented current diagnosis/treatment of cancer (including Sickle Cell Disease)

  6. Current treatment to the head/brain (radiation, whole brain therapy, gamma knife)

  7. Head injury in the last two years

  8. Unwilling to sign informed consent

  9. Pregnant or potentially pregnant

  10. Pacemaker, automatic implanted cardiac defibrillator or other implanted electrical device

  11. Connected to an electronic device that cannot be removed

  12. Missing all or part of fingers or cuts/burns on pads of fingers

  13. Long fingernails and unwilling to cut them and keep them cut for the duration of the study

  14. Hand tremors or involuntary oscillations ("shaking") of the hands that prevents clear imaging

Additional exclusion criteria for control population:

Previous head trauma

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Iowa Iowa City Iowa United States 52242

Sponsors and Collaborators

  • Epic Research & Diagnostics, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Epic Research & Diagnostics, Inc.
ClinicalTrials.gov Identifier:
NCT02471625
Other Study ID Numbers:
  • EPIC-011
First Posted:
Jun 15, 2015
Last Update Posted:
Nov 20, 2015
Last Verified:
Nov 1, 2015
Keywords provided by Epic Research & Diagnostics, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 20, 2015